Allocation in adult liver transplantation: is the Model for Endstage Liver Disease the solution?

Author(s):  
D. M. Heuman
2010 ◽  
Vol 23 (4) ◽  
pp. 350-357 ◽  
Author(s):  
Kensaku Sanefuji ◽  
Tomohiro Iguchi ◽  
Shigeru Ueda ◽  
Shigeyuki Nagata ◽  
Keishi Sugimachi ◽  
...  

1998 ◽  
Vol 2 (1) ◽  
pp. 187-210 ◽  
Author(s):  
John A. Goss ◽  
Rise Stribling ◽  
Paul Martin

2020 ◽  
Vol 1 (19) ◽  
pp. 39-46
Author(s):  
T. V. Pinchuk ◽  
N. V. Orlova ◽  
T. G. Suranova ◽  
T. I. Bonkalo

At the end of 2019, a new coronavirus (SARS-CoV-2) was discovered in China, causing the coronavirus infection COVID-19. The ongoing COVID-19 pandemic poses a major challenge to health systems around the world. There is still little information on how infection affects liver function and the significance of pre-existing liver disease as a risk factor for infection and severe COVID-19. In addition, some drugs used to treat the new coronavirus infection are hepatotoxic. In this article, we analyze data on the impact of COVID-19 on liver function, as well as on the course and outcome of COVID-19 in patients with liver disease, including hepatocellular carcinoma, or those on immunosuppressive therapy after liver transplantation.


1999 ◽  
Vol 384 (3) ◽  
pp. 259-263 ◽  
Author(s):  
C. A. Seiler ◽  
Jean-Francois Dufour ◽  
Eberhard L. Renner ◽  
Martin Schilling ◽  
Markus W. Büchler ◽  
...  

2021 ◽  
pp. 514-518
Author(s):  
Patrizia Burra ◽  
Salvatore Stefano Sciarrone ◽  
Patrizio Bo

Sign in / Sign up

Export Citation Format

Share Document